GT 08

Drug Profile

GT 08

Alternative Names: GT-08

Latest Information Update: 10 Jun 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Synergy Pharmaceuticals Pte Ltd
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Antibacterials; Benzimidazoles; Lactams; Lauric acids; Reducing agents; Sulfur amino acids
  • Mechanism of Action Free radical inhibitors; Mucin inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Helicobacter infections

Most Recent Events

  • 10 Jun 2014 No development reported - Phase-I/II for Helicobacter infections in Singapore (PO)
  • 11 May 2010 Phase-I/II clinical trials in Helicobacter infections in Singapore (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top